<p>Susquehanna Fundamental Investments LLC 在第四季度购买了 Waters Co.（纽约证券交易所代码：WAT - 免费报告）的新股份，具体信息在其最近向证券交易委员会的披露中显示。该基金购买了 2,300 股该医疗仪器供应商的股票，价值约 853,000 美元。</p>
<ul>
<li>安捷伦科技因 “永恒化学品” 打击而蓬勃发展</li>
</ul>
<p>其他几家机构投资者和对冲基金也对该公司的持仓进行了调整。先锋集团在第四季度将其在 Waters 的持股比例提高了 0.3%。先锋集团目前拥有 7,098,668 股该医疗仪器供应商的股票，价值 2,633,464,000 美元，此前在上个季度又购买了 19,456 股。Wealthfront Advisers LLC 在第四季度将其在 Waters 的持仓提高了 106,144.4%。Wealthfront Advisers LLC 目前拥有 3,087,461 股该医疗仪器供应商的股票，价值 1,145,386,000 美元，此前在上个季度又购买了 3,084,555 股。Alliancebernstein L.P. 在第四季度将其在 Waters 的持股提高了 8.7%。Alliancebernstein L.P. 目前拥有 2,654,002 股该医疗仪器供应商的股票，价值 984,582,000 美元，此前在上个季度又购买了 212,364 股。Geode Capital Management LLC 在第四季度将其在 Waters 的持仓提高了 2.5%。Geode Capital Management LLC 目前拥有 1,451,445 股该医疗仪器供应商的股票，价值 537,053,000 美元，此前在上个季度又购买了 34,762 股。最后，AKO Capital LLP 在第四季度将其在 Waters 的持股提高了 3.2%。AKO Capital LLP 目前拥有 815,379 股该医疗仪器供应商的股票，价值 302,489,000 美元，此前在上个季度又购买了 25,172 股。94.01% 的股票由机构投资者和对冲基金持有。</p>
<h2>分析师设定新目标价</h2>
<p>几家券商已对 WAT 发布了报告。瑞银集团将 Waters 的目标价从 405.00 美元上调至 410.00 美元，并在 2 月 13 日的报告中给予该股票 “中性” 评级。桑福德·C·伯恩斯坦在 4 月 16 日的研究报告中设定了 400.00 美元的目标价，并给予该股票 “跑赢大盘” 评级。富国银行将 Waters 的目标价从 415.00 美元上调至 420.00 美元，并在 2 月 13 日的报告中给予该公司 “增持” 评级。StockNews.com 在 2 月 25 日的研究报告中将 Waters 的评级从 “买入” 下调至 “持有”。最后，贝尔德 R W 在 3 月 26 日的研究报告中将 Waters 的评级从 “持有” 上调至 “强力买入”。十位股票研究分析师对该股票给予了 “持有” 评级，七位给予了 “买入” 评级，两位给予了 “强力买入” 评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “适度买入”，共识目标价为 392.13 美元。</p>
<ul>
<li>医疗股票 Waters、安捷伦、Illumina 显示增长潜力</li>
</ul>
<p><strong>查看我们关于 WAT 的最新报告</strong></p>
<h2>Waters 股票表现</h2>
<p>纽约证券交易所：WAT 周五开盘价为 351.16 美元。该公司的速动比率为 0.65，流动比率为 0.94，债务与股本比率为 1.14。Waters Co. 的 52 周低点为 279.24 美元，52 周高点为 423.56 美元。该公司的 50 日简单移动平均线为 352.54 美元，200 日简单移动平均线为 369.92 美元。该股票的市值为 208.9 亿美元，市盈率为 32.79，市盈增长比率为 3.79，贝塔值为 1.04。</p>
<p>Waters（纽约证券交易所：WAT - 获取免费报告）最近在 2 月 12 日星期三发布了季度财报。该医疗仪器供应商报告每股收益（EPS）为 4.10 美元，超出分析师共识预期的 4.02 美元，超出幅度为 0.08 美元。Waters 的净利润率为 21.56%，股本回报率为 46.31%。分析师预计 Waters Co. 在当前财年将发布 12.86 美元的每股收益。</p>
<h2>Waters 公司简介</h2>
<p>（免费报告）</p>
<p>Waters Corporation 在亚洲、美洲和欧洲提供分析工作流程解决方案。它通过两个部门运营：Waters 和 TA。该公司设计、制造、销售和服务高效和超高效液相色谱以及质谱（MS）技术系统和支持产品，包括色谱柱、其他消耗品和保修后服务计划。</p>
<h2>了解更多</h2>
<ul>
<li>我们更看好的五只股票比 Waters 更好</li>
<li>3 只股票保护您的投资组合免受冠状病毒传播影响</li>
<li>Meta 在第一季度财报中表现出色 - 注意第二季度的关税影响</li>
<li>什么是纳斯达克证券交易所？</li>
<li>亚马逊财报：2 个值得关注的理由，1 个需要谨慎的理由</li>
<li>5 美元以下的最佳股票</li>
<li>Palantir 财报：1 个看涨信号和 1 个关注领域</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdBVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdBVA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Waters 吗？</h2>
<p>在考虑投资 Waters 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Waters 并不在其中。</p>
<p>虽然 Waters 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

沃特世

<p>Susquehanna Fundamental Investments LLC 已经在沃特世 (NYSE:WAT) 中获得了新的股份，购买了价值约 853,000 美元的 2,300 股。其他机构投资者，包括先锋集团和 Wealthfront Advisers，也增加了他们在沃特世的持仓。分析师为该股票设定了新的价格目标，普遍评级为 “适度买入”，目标价格为 392.13 美元。沃特世报告每股收益为 4.10 美元，超出预期，市值为 208.9 亿美元</p>

<p>Susquehanna Fundamental Investments LLC purchased a new position in shares of Waters Co. (NYSE:WAT - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 2,300 shares of the medical instruments supplier's stock, valued at approximately $853,000.</p>
<div class="lb-trans"><p>Susquehanna Fundamental Investments LLC 在第四季度购买了 Waters Co.（纽约证券交易所代码：WAT - 免费报告）的新股份，具体信息在其最近向证券交易委员会的披露中显示。该基金购买了 2,300 股该医疗仪器供应商的股票，价值约 853,000 美元。</p>
</div><ul>
<li>Agilent Technologies Thrives From the Forever Chemicals Crackdown</li>
</ul>
<div class="lb-trans"><ul>
<li>安捷伦科技因 “永恒化学品” 打击而蓬勃发展</li>
</ul>
</div><p>Several other institutional investors and hedge funds have also made changes to their positions in the business. Vanguard Group Inc. lifted its stake in Waters by 0.3% during the fourth quarter. Vanguard Group Inc. now owns 7,098,668 shares of the medical instruments supplier's stock worth $2,633,464,000 after purchasing an additional 19,456 shares during the last quarter. Wealthfront Advisers LLC lifted its position in shares of Waters by 106,144.4% during the 4th quarter. Wealthfront Advisers LLC now owns 3,087,461 shares of the medical instruments supplier's stock worth $1,145,386,000 after buying an additional 3,084,555 shares during the last quarter. Alliancebernstein L.P. boosted its holdings in shares of Waters by 8.7% in the 4th quarter. Alliancebernstein L.P. now owns 2,654,002 shares of the medical instruments supplier's stock valued at $984,582,000 after buying an additional 212,364 shares in the last quarter. Geode Capital Management LLC grew its position in shares of Waters by 2.5% in the 4th quarter. Geode Capital Management LLC now owns 1,451,445 shares of the medical instruments supplier's stock valued at $537,053,000 after buying an additional 34,762 shares during the last quarter. Finally, AKO Capital LLP raised its stake in Waters by 3.2% during the 4th quarter. AKO Capital LLP now owns 815,379 shares of the medical instruments supplier's stock worth $302,489,000 after acquiring an additional 25,172 shares in the last quarter. 94.01% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他几家机构投资者和对冲基金也对该公司的持仓进行了调整。先锋集团在第四季度将其在 Waters 的持股比例提高了 0.3%。先锋集团目前拥有 7,098,668 股该医疗仪器供应商的股票，价值 2,633,464,000 美元，此前在上个季度又购买了 19,456 股。Wealthfront Advisers LLC 在第四季度将其在 Waters 的持仓提高了 106,144.4%。Wealthfront Advisers LLC 目前拥有 3,087,461 股该医疗仪器供应商的股票，价值 1,145,386,000 美元，此前在上个季度又购买了 3,084,555 股。Alliancebernstein L.P. 在第四季度将其在 Waters 的持股提高了 8.7%。Alliancebernstein L.P. 目前拥有 2,654,002 股该医疗仪器供应商的股票，价值 984,582,000 美元，此前在上个季度又购买了 212,364 股。Geode Capital Management LLC 在第四季度将其在 Waters 的持仓提高了 2.5%。Geode Capital Management LLC 目前拥有 1,451,445 股该医疗仪器供应商的股票，价值 537,053,000 美元，此前在上个季度又购买了 34,762 股。最后，AKO Capital LLP 在第四季度将其在 Waters 的持股提高了 3.2%。AKO Capital LLP 目前拥有 815,379 股该医疗仪器供应商的股票，价值 302,489,000 美元，此前在上个季度又购买了 25,172 股。94.01% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>Several brokerages have issued reports on WAT. UBS Group raised their price objective on Waters from $405.00 to $410.00 and gave the stock a &#34;neutral&#34; rating in a report on Thursday, February 13th. Sanford C. Bernstein set a $400.00 price target on Waters and gave the stock an &#34;outperform&#34; rating in a research report on Wednesday, April 16th. Wells Fargo &amp; Company increased their price objective on Waters from $415.00 to $420.00 and gave the company an &#34;overweight&#34; rating in a report on Thursday, February 13th. StockNews.com lowered shares of Waters from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research report on Tuesday, February 25th. Finally, Baird R W upgraded shares of Waters from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research note on Wednesday, March 26th. Ten equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $392.13.</p>
<div class="lb-trans"><p>几家券商已对 WAT 发布了报告。瑞银集团将 Waters 的目标价从 405.00 美元上调至 410.00 美元，并在 2 月 13 日的报告中给予该股票 “中性” 评级。桑福德·C·伯恩斯坦在 4 月 16 日的研究报告中设定了 400.00 美元的目标价，并给予该股票 “跑赢大盘” 评级。富国银行将 Waters 的目标价从 415.00 美元上调至 420.00 美元，并在 2 月 13 日的报告中给予该公司 “增持” 评级。StockNews.com 在 2 月 25 日的研究报告中将 Waters 的评级从 “买入” 下调至 “持有”。最后，贝尔德 R W 在 3 月 26 日的研究报告中将 Waters 的评级从 “持有” 上调至 “强力买入”。十位股票研究分析师对该股票给予了 “持有” 评级，七位给予了 “买入” 评级，两位给予了 “强力买入” 评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “适度买入”，共识目标价为 392.13 美元。</p>
</div><ul>
<li>Medical Stocks Waters, Agilent, Illumina Show Growth Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>医疗股票 Waters、安捷伦、Illumina 显示增长潜力</li>
</ul>
</div><p><strong>Check Out Our Latest Report on WAT</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 WAT 的最新报告</strong></p>
</div><h2>Waters Stock Performance</h2>
<div class="lb-trans"><h2>Waters 股票表现</h2>
</div><p>NYSE:WAT opened at $351.16 on Friday. The company has a quick ratio of 0.65, a current ratio of 0.94 and a debt-to-equity ratio of 1.14. Waters Co. has a fifty-two week low of $279.24 and a fifty-two week high of $423.56. The firm's fifty day simple moving average is $352.54 and its 200-day simple moving average is $369.92. The stock has a market cap of $20.89 billion, a PE ratio of 32.79, a price-to-earnings-growth ratio of 3.79 and a beta of 1.04.</p>
<div class="lb-trans"><p>纽约证券交易所：WAT 周五开盘价为 351.16 美元。该公司的速动比率为 0.65，流动比率为 0.94，债务与股本比率为 1.14。Waters Co. 的 52 周低点为 279.24 美元，52 周高点为 423.56 美元。该公司的 50 日简单移动平均线为 352.54 美元，200 日简单移动平均线为 369.92 美元。该股票的市值为 208.9 亿美元，市盈率为 32.79，市盈增长比率为 3.79，贝塔值为 1.04。</p>
</div><p>Waters (NYSE:WAT - Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%. Analysts expect that Waters Co. will post 12.86 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Waters（纽约证券交易所：WAT - 获取免费报告）最近在 2 月 12 日星期三发布了季度财报。该医疗仪器供应商报告每股收益（EPS）为 4.10 美元，超出分析师共识预期的 4.02 美元，超出幅度为 0.08 美元。Waters 的净利润率为 21.56%，股本回报率为 46.31%。分析师预计 Waters Co. 在当前财年将发布 12.86 美元的每股收益。</p>
</div><h2>Waters Company Profile</h2>
<div class="lb-trans"><h2>Waters 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.</p>
<div class="lb-trans"><p>Waters Corporation 在亚洲、美洲和欧洲提供分析工作流程解决方案。它通过两个部门运营：Waters 和 TA。该公司设计、制造、销售和服务高效和超高效液相色谱以及质谱（MS）技术系统和支持产品，包括色谱柱、其他消耗品和保修后服务计划。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Waters</li>
<li>3 Stocks to Protect Your Portfolio from the Coronavirus Contagion</li>
<li>Meta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2</li>
<li>What is the NASDAQ Stock Exchange?</li>
<li>Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be Cautious</li>
<li>Best Stocks Under $5.00</li>
<li>Palantir Earnings: 1 Bullish Signal and 1 Area of Concern</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Waters 更好</li>
<li>3 只股票保护您的投资组合免受冠状病毒传播影响</li>
<li>Meta 在第一季度财报中表现出色 - 注意第二季度的关税影响</li>
<li>什么是纳斯达克证券交易所？</li>
<li>亚马逊财报：2 个值得关注的理由，1 个需要谨慎的理由</li>
<li>5 美元以下的最佳股票</li>
<li>Palantir 财报：1 个看涨信号和 1 个关注领域</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdBVA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=WAT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Waters Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Waters 吗？</h2>
</div><p>Before you consider Waters, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑投资 Waters 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Waters 并不在其中。</p>
</div><p>While Waters currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Waters 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Susquehanna Fundamental Investments LLC 购入了沃特世公司（NYSE:WAT）的新股权